The current study provides clinical and genetic evidence, which extends the phenotypic spectrum of PRPF8-, PRPH2-, RP1-, and RPGR-associated disease, and the genotypic spectrum of LCA/EOSRD. This evidence concerns the gene RPGR and severe early-childhood-onset retinal dystrophy.